20 LATEST RESOURCES (57 INDEXED)
×
Antipsychotic Adherence, Resource Use, and Costs Before and After the Initiation of Once-Monthly Paliperidone Palmitate Therapy among Medicaid Beneficiaries with Prior Schizophrenia Relapse · February 2021
Abstracts
Clinical Therapeutics
×
Associations of Substance Use, Psychosis, and Mortality among People Living in Precarious Housing or Homelessness: A Longitudinal, Community-Based Study in Vancouver, Canada · July 2020
Articles
PLOS Medicine
×
Projecting the Long-Term Economic Impact of Once-Monthly Paliperidone Palmitate versus Oral Atypical Antipsychotics in Medicaid Patients with Schizophrenia · February 2020
Articles
Journal of Managed Care and Specialty Pharmacy
×
Factors Associated with the Initiation of Long-Acting Injectable Paliperidone Palmitate versus Aripiprazole among Medicaid Patients with Schizophrenia: An Observational Study · March 2019
Abstracts
Advances in Therapy
×
Substance Dependence among Bipolar, Unipolar Depression and Psychotic Homeless: A Canadian National Study · December 2018
Articles
Frontiers in Psychiatry
×
Extent of Use of Long-Acting Injectable Antipsychotics in Children and Adolescents within Indiana Medicaid · September 2018
Articles
Mental Health Clinician
×
Projecting the Potential Effect of Using Paliperidone Palmitate Once-Monthly and Once-Every-3-Months Long-Acting Injections among Medicaid Beneficiaries with Schizophrenia · August 2018
Articles
Journal of Managed Care and Specialty Pharmacy
×
A Systematic Literature Review of the Clinical and Health Economic Burden of Schizophrenia in Privately Insured Patients in the United States · June 2018
Articles
ClinicoEconomics and Outcomes Research
×
Economic Impact in Medicaid Beneficiaries with Schizophrenia and Cardiometabolic Comorbidities Treated with Once-Monthly Paliperidone Palmitate vs. Oral Atypical Antipsychotics · January 2018
Articles
Drugs-Real World Outcomes
×
A 6-Month Prospective Trial of a Personalized Behavioral Intervention + Long-Acting Injectable Antipsychotic in Individuals with Schizophrenia at Risk for Treatment Non-Adherence and Homelessness · December 2017
Articles (Manuscripts-Versions)
PubMed Central>Journal of Clinical Psychopharmacology
×
Characteristics of Medicaid Recipients Receiving Persistent Antipsychotic Polypharmacy · November 2017
Articles (Manuscripts-Versions)
PubMed Central>Community Mental Health Journal
×
Real-World Adherence and Economic Outcomes Associated with Paliperidone Palmitate versus Oral Atypical Antipsychotics in Schizophrenia Patients with Substance-Related Disorders Using Medicaid Benefits · August 2017
Articles
Journal of Comparative Effectiveness Research
×
Treatment Patterns in Medicaid Patients with Schizophrenia Initiated on a First- or Second-Generation Long-Acting Injectable versus Oral Antipsychotic · March 2017
Articles
Patient Preference and Adherence
×
Influence of Socioeconomic Status on Antipsychotic Prescriptions among Youth in France · February 2017
Articles
BMC Psychiatry
×
Relevance of a Subjective Quality of Life Questionnaire for Long-Term Homeless Persons with Schizophrenia · February 2017
Articles
BMC Psychiatry
×
Prescribing of Clozapine and Antipsychotic Polypharmacy for Schizophrenia in a Large Medicaid Program · February 2017
Articles
Psychiatric Services
×
Housing First Improves Adherence to Antipsychotic Medication among Formerly Homeless Adults with Schizophrenia: Results of a Randomized Controlled Trial · September 2016
Articles
Schizophrenia Bulletin
×
Schizophrenia and Subsequent Neighborhood Deprivation: Revisiting the Social Drift Hypothesis Using Population, Twin and Molecular Genetic Data · May 2016
Articles
Translational Psychiatry